Description
The Department of Veterans Affairs intends to award a sole‑source, firm‑fixed‑price contract to Optum Pharmacy 801, Inc. for the compounding, packaging, and delivery of high‑danger (HD) chemotherapy drugs to the VA East Orange, NJ campus. The contractor must follow USP 797/800, FDA regulations, and VA shipping requirements, delivering sterile, refrigerated products by 8:00 am on treatment days. Capability statements are accepted until September 9, 2026.
• Sole‑source award to Optum Pharmacy 801, Inc. (large business)
• Services: aseptic compounding of HD chemotherapy agents, labeling, hazardous packaging, refrigerated shipping, same‑day delivery to East Orange VA clinic
• Must comply with USP 797, USP 800, FDA guidelines, and VA drug‑stability requirements
• Quantity list includes dozens of agents (e.g., ADCETRIS, ONIVYDE, PACLITAXEL, etc.) with estimated unit counts ranging from 4 to 660 each
• Capability statements due 09‑09‑2026 10:00 AM EST; no formal RFP, but interested parties may submit statements for consideration
• Point of contact: Morgan Weeks, Contracting Officer (email & phone provided)